Europe Epilepsy Devices Market Forecast 2022-2030

Europe Epilepsy Devices Market Forecast 2022-2030


The Europe epilepsy devices market is anticipated to grow with a 7.61% CAGR during the estimated period 2022-2030. The technological advancements in therapeutic devices, the growing geriatric population prone to epilepsy, and reimbursement availability drive the Europe market growth.


The Europe epilepsy devices market growth evaluation entails an assessment of Germany, Italy, Nordic Countries, Spain, United Kingdom, France, and Rest of Europe. Geographic and socioeconomic factors may impact epilepsy prevalence. The Nordic nations are not only close geographically, but they also have a lot of similarities in their cultures, standards of living, and economy. Publicly subsidized, all-encompassing healthcare systems protect the Nordic region’s whole resident population. The resultant ever-growing aging population, early detection and diagnosis of epilepsy among the population, and various medical therapies have increased the market for epilepsy devices in Nordic Countries.

In Spain, epilepsy affects more than 4,000 children annually. Refractory epilepsy, or epilepsy that does not respond to medication, affects one in three people. Drug-resistant forms of epilepsy place a heavy strain on patients and their families. With recurring crises, underlying neurological conditions, medication side effects, and societal stigmatization, patients present major medical and social problems.

As a result, epilepsy treatments involving vagus nerve stimulation, deep brain stimulation, accelerometer, and neurostimulation will gain popularity throughout the anticipated period. Spain is also aiming to develop modern healthcare systems that will make available more affordable and effective solutions for the general people, increasing demand for epilepsy equipment.


Some of the key players include Philips NV, LivaNova PLC, NeuroPace Inc, Nihon Kohden Corporation, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Soaring Occurrences Of Epilepsy Globally
3.1.2. Onset Of Epilepsy In Elderly People
3.1.3. Mitigation Of Epilepsy Using Early Diagnosis
3.1.4. Surge In Post-traumatic Epilepsy With Rising Brain Injury Cases
3.2. Key Restraints
3.2.1. Misperceptions And Misinformation About Epilepsy
3.2.2. Shortage Of Neurology Specialists In The Healthcare System
4. Key Analytics
4.1. Impact Of Covid-19 On Epilepsy Devices Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Comfort & Usability
4.7.2. Product Features
4.7.3. Confidentiality
4.8. Regulatory Framework
5. Market By Product Type
5.1. Conventional Devices
5.2. Wearable Devices
5.2.1. Watches
5.2.2. Bracelets
5.2.3. Camera Devices
5.2.4. Mattress Devices
5.2.5. Anti-suffocation Pillows
5.2.6. Other Wearable Devices
5.3. Implantable Devices
6. Market By Technology
6.1. Vagus Nerve Stimulation
6.2. Deep Brain Stimulation
6.2.1. Movement Disorders
6.2.2. Epilepsy
6.3. Accelerometry
6.4. Responsive Neurostimulation
7. Market By Detection & Prediction Devices Type
7.1. Electroencephalogram
7.2. Intracranial Eeg
7.3. Surface Electromyography
7.4. Electrocardiography
7.5. Video Detection Systems
7.6. Electrodermal Activity
7.7. Implanted Advisory Systems
7.8. Other Detection & Prediction Device Types
8. Market By End-user
8.1. Hospitals & Clinics
8.2. Neurology Centers
8.3. Home Care Settings
8.4. Other End-users
9. Geographical Analysis
9.1. Europe
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis United Kingdom Germany France Italy Spain Nordic Countries Rest Of Europe
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships
10.2. Company Profiles
10.2.1. Boston Scientific Corporation
10.2.2. Cadwell Industries Inc
10.2.3. Compumedics Limited
10.2.4. Drägerwerk Ag & Co Kgaa
10.2.5. Empatica Inc
10.2.6. Koninklijke Philips Nv
10.2.7. Livanova Plc
10.2.8. Medtronic Plc
10.2.9. Natus Medical Incorporated
10.2.10. Neuropace Inc
10.2.11. Neurosoft
10.2.12. Nihon Kohden Corporation
10.2.13. Shenzhen Mindray Bio-medical Electronics Co Ltd

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings